PDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to Chemotherapy

被引:0
|
作者
Mathur, Sandeep [1 ]
Johnson, Anjana [2 ]
Deo, S. V. S. [1 ]
Gogia, Ajay [1 ]
Kahol, Shruti [1 ]
Jain, Deepali [1 ]
Iyer, Venkateswaran [1 ]
机构
[1] All India Inst Med Sci, New Delhi, India
[2] All India Inst Med Sci, Delhi, India
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
214
引用
收藏
页码:208 / 209
页数:2
相关论文
共 50 条
  • [1] PDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to Chemotherapy
    Mathur, Sandeep
    Johnson, Anjana
    Deo, S. V. S.
    Gogia, Ajay
    Kahol, Shruti
    Jain, Deepali
    Iyer, Venkateswaran
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 208 - 209
  • [2] Modulation by treatment of tumor infiltrating lymphocytes (TILs) and PDL1 expression in triple-negative breast cancer in the ETNA trial.
    Bianchini, Giampaolo
    Smart, Chanel
    Mansutti, Mauro
    Luck, Hans-Joachim
    Zambelli, Stefania
    Olier, Clara
    Anton, Antonio
    Bisagni, Giancarlo
    Merlini, Laura
    Murillo, Serafin Morales
    Martinez, Lourdes Calvo
    Chacon, Jose Ignacio
    Semiglazov, Vladimir
    Thill, Marc
    Chan, Arlene
    Tusquets, Ignasi
    Licata, Luca
    Valagussa, Pinuccia
    Viale, Giuseppe
    Gianni, Luca
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] PDL1 expression and its correlation with outcomes in non-metastatic triple-negative breast cancer (TNBC)
    Ghosh, Joydeep
    Chatterjee, Meheli
    Ganguly, Sandip
    Datta, Anuparva
    Biswas, Bivas
    Mukherjee, Geetashree
    Agarwal, Sanjit
    Ahmed, Rosina
    Chatterjee, Sanjoy
    Dabkara, Deepak
    ECANCERMEDICALSCIENCE, 2021, 15
  • [4] Relationship among PDL1, androgen receptor (AR) and tumour infiltrating lymphocytes (TILs) in early triple negative breast cancer
    Sanchez-Cousido, L. F.
    Honrado Franco, E.
    Sanz Guadarrama, O.
    Lopez Gonzalez, L.
    Garcia-Palomo, A.
    Lopez Flores, M.
    Rojas Piedra, M.
    Tavara Silva, B.
    Delgado Sillero, I.
    Castanon Lopez, C.
    Diz Tain, P.
    Rodriguez Sanchez, A.
    Nieto Mangudo, B.
    Lopez-Gonzalez, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S328 - S329
  • [5] Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management
    Gorensek, Rok
    Kresnik, Martin
    Takac, Iztok
    Rojko, Tomaz
    Sobocan, Monika
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 773 - 783
  • [6] Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Makiko Ono
    Hitoshi Tsuda
    Chikako Shimizu
    Sohei Yamamoto
    Tatsuhiro Shibata
    Harukaze Yamamoto
    Taizo Hirata
    Kan Yonemori
    Masashi Ando
    Kenji Tamura
    Noriyuki Katsumata
    Takayuki Kinoshita
    Yuichi Takiguchi
    Hideki Tanzawa
    Yasuhiro Fujiwara
    Breast Cancer Research and Treatment, 2012, 132 : 793 - 805
  • [7] Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Ono, Makiko
    Tsuda, Hitoshi
    Shimizu, Chikako
    Yamamoto, Sohei
    Shibata, Tatsuhiro
    Yamamoto, Harukaze
    Hirata, Taizo
    Yonemori, Kan
    Ando, Masashi
    Tamura, Kenji
    Katsumata, Noriyuki
    Kinoshita, Takayuki
    Takiguchi, Yuichi
    Tanzawa, Hideki
    Fujiwara, Yasuhiro
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (03) : 793 - 805
  • [8] Correlation of Clinicopathological Features and LGR5 Expression in Triple-Negative Breast Cancer
    Ogasawara, Souya
    Uehara, Takeshi
    Nakajima, Tomoyuki
    Iwaya, Mai
    Maeno, Kazuma
    Tsuchiya, Shinichi
    Ota, Hiroyoshi
    Ito, Ken-ichi
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 46
  • [9] PDL1 protein expression is a prognostic factor in triple negative breast cancer
    Yue, J.
    Yuan, P.
    Zhu, A.
    Hu, N.
    Wang, X.
    Wang, W.
    Wang, Z.
    ANNALS OF ONCOLOGY, 2020, 31 : S30 - S31
  • [10] PDL1 and PD1 expression by tumor infiltrating lymphocytes in primary breast cancer
    Solinas, C.
    Buisseret, L.
    Garaud, S.
    Boisson, A.
    Naveaux, C.
    de Wind, R.
    Van den Eynden, G.
    Brown, D.
    Larsimont, D.
    Sotiriou, C.
    Willard-Gallo, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 4 - 4